3.12.2025 10:07:13 CET | Demant A/S |
Finanskalender
Selskabsmeddelelse nr. 2025-14 3. december 2025
Finanskalender for 2026
21. januar
Frist for indlevering af emner til dagsordenen for den ordinære generalforsamling*
13. januar til 2. februar
Stilleperiode forud for offentliggørelse af Annual Report 2025 (årsrapport for 2025)
3. februar
Årsrapport 2025
5. marts
Ordinær generalforsamling
15. april til 5. maj
Stilleperiode forud for offentliggørelse af periodemeddelelse
5. maj
Periodemeddelelse for Q1 2026
22. juli til 11. august
Stilleperiode forud for offentliggørelse af Interim Report 2026 (halvårsrapport for 2026)
11. august
Halvårsrapport 2026
14. oktober til 3. november
Stilleperiode forud for offentliggørelse af periodemeddelelse
3. november
Periodemeddelelse for Q3 2026
* Såfremt en aktionær ønsker et bestemt emne behandlet på den ordinære generalforsamling den 5. marts 2026, skal begæring herom indsendes skriftligt til bestyrelsen senest seks uger inden afholdelse af generalforsamlingen, således at begæringen er bestyrelsen i hænde senest den 21. januar 2026.
Yderligere information:
Peter Pudselykke, Head of Investor Relations
Telefon +45 2830 7638
Gustav Høegh, Investor Relations Officer
Telefon +45 5350 0114www.demant.com
Kontakter
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2025-14 Finanskalender 2026.pdf
3.12.2025 10:07:13 CET | Demant A/S |
Financial Calendar
Company announcement no 2025-14 3 December 2025
Financial calendar 2026
21 January
Deadline for submission of items for the agenda of the annual general meeting*
13 January to 2 February
Quiet period prior to publication of Annual Report 2025
3 February
Annual Report 2025
5 March
Annual general meeting
15 April to 5 May
Quiet period prior to publication of Interim Management Statement
5 May
Interim Management Statement for Q1 2026
22 July to 11 August
Quiet period prior to publication of Interim Report 2026
11 August
Interim Report 2026
14 October to 3 November
Quiet period prior to publication of Interim Management Statement
3 November
Interim Management Statement for Q3 2026
* Please note that if a shareholder would like to have a specific item included on the agenda for the annual general meeting on 5 March 2026, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 21 January 2026.
Further information:
Peter Pudselykke, Head of Investor Relations
Phone +45 2830 7638
Gustav Høegh, Investor Relations Officer
Phone +45 5350 0114
www.demant.com
Contacts
Henrik Axel Lynge Buchter, External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2025-14 Financial calendar 2026.pdf
